Drug Markets/Nilotinib

Nilotinib

2 NDCs across 1 manufacturer|0 Generic,2 Brand

Nilotinib is used to treat gastrointestinal stromal tumors, leukemia, myeloid, accelerated phase and leukemia, myeloid, chronic-phase, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on May 29, 2026.

Nilotinib is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $94.15 to $94.15 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

0G / 2B

Manufacturers

1

competing in market

Price Spread

$94.15 – $94.15

per EA

7d Activity

2 flat

avg +0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing NILOTINIB

Drug Portfolio

2 NDCs total, 2 shown

Drug ↕Price 7d Change ↕
TASIGNA 200 MG CAPSULE
$94.1452
per EA
—
TASIGNA 200 MG CAPSULE
$94.1452
per EA
—

Frequently Asked Questions

What is Nilotinib used to treat?

Nilotinib is used to treat gastrointestinal stromal tumors, leukemia, myeloid, accelerated phase and leukemia, myeloid, chronic-phase, per the National Library of Medicine's MED-RT classification.

How many Nilotinib products are on the market?

The Nilotinib drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.

What is the price range for Nilotinib?

NADAC reference prices for Nilotinib range from $94.1452 to $94.1452 per EA.

Which manufacturers make Nilotinib?

1 manufacturer lists Nilotinib in NADAC. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (2).